Sohomoy
Decitabine Drug Market: Revolutionizing Myeloid Care, Dosing Convenience, and Clinical Workflows
Rising global incidence of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), aging demographics, and ongoing formulation advances across injectable and oral hypomethylating regimens are shaping the global Decitabine Drug Market, with reported forecast trajectories tracking a 4.4% CAGR from 2026 to 2035 (and broader industry estimates spanning USD 2.8 billion in 2025 toward USD...
8 Views